Loading…
Lifecore Biomedical, Inc. is projected to rise to $6.70 by 2027, a +41% move from its current price of $4.75. LFCR is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/12/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 13 | $4.61 | $4.75 | $4.90 | +0.10% |
| Jul 14 | $4.56 | $4.76 | $4.97 | +0.20% |
| Jul 15 | $4.52 | $4.76 | $5.02 | +0.30% |
| Jul 16 | $4.49 | $4.77 | $5.07 | +0.40% |
| Jul 17 | $4.46 | $4.77 | $5.11 | +0.50% |
| Jul 18 | $4.43 | $4.78 | $5.15 | +0.60% |
| Jul 19 | $4.41 | $4.78 | $5.19 | +0.71% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $4.41 | $4.78 | $5.19 | +0.71% |
| Week 2 | $4.30 | $4.82 | $5.40 | +1.42% |
| Week 3 | $4.22 | $4.85 | $5.58 | +2.13% |
| Week 4 | $4.15 | $4.89 | $5.75 | +2.85% |
| Week 5 | $4.10 | $4.92 | $5.90 | +3.58% |
| Week 6 | $4.06 | $4.95 | $6.04 | +4.31% |
| Week 7 | $4.03 | $4.99 | $6.18 | +5.04% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Lifecore Biomedical, Inc., together with its subsidiaries, operates as an integrated contract development and manufacturing organization that serves customers in the United States, Belgium, the Netherlands, and internationally. It provides services in the development, manufacture, aseptic fill, and finish of formulations and highly viscous sterile injectable pharmaceutical drug or medical device products in syringes, vials, and cartridges in various modalities.
The company also manufactures and sells pharmaceutical-grade hyaluronic acid in bulk form, as well as for use in formulated and filled syringes and vials for injectable products used in treating various medical conditions and procedures, including ophthalmic and orthopedic applications. In addition, it offers product development services, including analytical method development and validation, formulation development, sterile filtration, process scale-up, pilot studies, stability studies, process validation, and materials production for clinical studies.
It was formerly known as Landec Corporation and changed its name to Lifecore Biomedical, Inc. in November 2022. Lifecore Biomedical, Inc. was founded in 1965 and is headquartered in Chaska, Minnesota.
Current price: $4.57. Market cap: $171.42M. Rank: 3921. The stock sits in the healthcare sector and has a market position reflected by its rank and capitalization. The price outlook from the forecast shows a path of rising averages and notable upside across the next several years, starting near the current level and expanding toward the late 2020s and beyond.
A major floor 22.9% below — a decisive break under it would weaken the trend.
The nearest floor, 3.8% below — buyers have tended to step in here.
The nearest ceiling, 22.1% above — a clean break opens room to run.
A major ceiling 48.6% above — clearing it would confirm fresh momentum.
Key LFCR support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of LFCR market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $4.80 | Sell | $4.81 | Sell |
| MA 10 | $4.97 | Sell | $4.96 | Sell |
| MA 20 | $5.26 | Sell | $5.11 | Sell |
| MA 50 | $5.10 | Sell | $5.20 | Sell |
| MA 100 | $5.29 | Sell | $5.51 | Sell |
| MA 200 | $6.42 | Sell | $6.02 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 39.77 | Neutral |
| Stoch RSI (14) | 17.87 | Buy |
| CCI (20) | -117.04 | Sell |
| Williams %R (14) | -85.37 | Info |
| MACD (12,26,9) | -0.10 | Sell |
| ROC (12) | -16.08 | Sell |
| Bollinger %B (20,2) | 0.13 | Neutral |
| Stochastic %K (14) | 14.63 | Buy |
| TRIX (15) | -0.05 | Sell |
| Awesome (5,34) | -0.47 | Sell |
| Ultimate (7,14,28) | 28.79 | Buy |
| Momentum (10) | -0.64 | Sell |
| Aroon Osc (25) | -36.00 | Sell |
| Hull MA (9) | 4.59 | Buy |
| ADX (14) | 17.18 | Neutral |
| ATR (14) | 0.15 | Info |
The near-term technical picture is bearish, with RSI14 at 30, indicating cooldown pressure. The stock trades with a daily pattern that suggests caution around near-term downside risk before any potential rebound.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $3.66 | $4.75 | $7.16 | 0% | Neutral | |
| $5.27 | $6.70 | $9.04 | +41% | Bullish | |
| $5.76 | $7.56 | $10.62 | +59% | Bullish | |
| $6.52 | $8.78 | $12.74 | +85% | Bullish | |
| $6.40 | $8.82 | $13.15 | +86% | Bullish | |
| $6.55 | $9.22 | $14.07 | +94% | Bullish | |
| $6.91 | $9.92 | $15.46 | +109% | Bullish | |
| $7.69 | $11.25 | $17.86 | +137% | Bullish | |
| $9.66 | $14.40 | $23.25 | +203% | Bullish | |
| $10.20 | $15.46 | $25.37 | +225% | Bullish | |
| $12.69 | $20.81 | $36.51 | +338% | Bullish | |
| $22.87 | $43.01 | $83.13 | +805% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $3.66 | $4.75 | $5.66 | +0.00% |
| August 2026 | $4.20 | $4.97 | $6.05 | +4.61% |
| September 2026 | $4.36 | $5.21 | $6.42 | +4.75% |
| October 2026 | $4.34 | $5.21 | $6.50 | +0.14% |
| November 2026 | $4.42 | $5.34 | $6.71 | +2.43% |
| December 2026 | $4.65 | $5.65 | $7.16 | +5.81% |
Click any year to see its month-by-month LFCR forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
By 2026, LFCR could reach as high as $7.16, with a base case around $4.75 and support toward $3.66 — roughly 0% from $4.75. Price action looks broadly range-bound.
Expect LFCR to range from $5.27 to $9.04 through 2027. The $6.70 average target implies a +41% move from current prices. That is up +41% on the projected 2026 average. Buyers look set to stay in control over this stretch.
The LFCR price prediction for 2028 points to an average of $7.56 (low $5.76, high $10.62) — a potential gain of +59% on today's $4.75. Momentum favours further upside here.
In 2029, LFCR is projected to trade between $6.52 and $12.74, averaging $8.78 — a potential gain of +85% from today's $4.75. That is up +16% on the projected 2028 average. Buyers look set to stay in control over this stretch.
Lifecore Biomedical, Inc.'s 2030 outlook centres on $8.82, within a $6.40 to $13.15 range. That is up 0% on the projected 2029 average. That marks a +86% change versus current levels. Momentum favours further upside here.
By 2031, LFCR could reach as high as $14.07, with a base case around $9.22 and support toward $6.55 — roughly +94% from $4.75. Buyers look set to stay in control over this stretch.
Expect LFCR to range from $6.91 to $15.46 through 2032. The $9.92 average target implies a +109% move from current prices. That is up +8% on the projected 2031 average. Momentum favours further upside here.
The LFCR price prediction for 2033 points to an average of $11.25 (low $7.69, high $17.86) — a potential gain of +137% on today's $4.75. Buyers look set to stay in control over this stretch.
In 2034, LFCR is projected to trade between $9.66 and $23.25, averaging $14.40 — a potential gain of +203% from today's $4.75. That is up +28% on the projected 2033 average. Momentum favours further upside here.
Lifecore Biomedical, Inc.'s 2035 outlook centres on $15.46, within a $10.20 to $25.37 range. That is up +7% on the projected 2034 average. That marks a +225% change versus current levels. Buyers look set to stay in control over this stretch.
By 2040, LFCR could reach as high as $36.51, with a base case around $20.81 and support toward $12.69 — roughly +338% from $4.75. Momentum favours further upside here.
Expect LFCR to range from $22.87 to $83.13 through 2050. The $43.01 average target implies a +805% move from current prices. That is up +107% on the projected 2040 average. Buyers look set to stay in control over this stretch.
Investing $1,000 in LFCR today (≈ 210.526316 LFCR) could be worth
$9,054.25
+$8,054.25 (+805%) by 2050 · US Dollar
Based on the average projected LFCR price of $43.01 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in LFCRwould be worth at today's price.
$1,000 invested in LFCR on Jul 10, 2025 (≈ 113.89522 LFCR) would be worth
$541
-$459 (-45.9%) today · 0.54× · US Dollar
Based on a LFCR entry price of $8.78 vs. today's $4.75.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $5.09 | $933.2 | -6.7% |
| 1 month ago | $5.69 | $834.8 | -16.5% |
| 3 months ago | $4.75 | $1,000 | 0.0% |
| 6 months ago | $7.59 | $625.82 | -37.4% |
| 1 year ago | $8.78 | $541 | -45.9% |
| All time (5.0y) ago | $11.32 | $419.61 | -58.0% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our LFCR forecast.
Our base-case forecast reaches $9.50 around 2032.
Implied market cap at $9.50: $356.34M
Forecasts show a bullish multi-year trajectory after 2026. In 2026 the min is $3.66, the avg is $4.57, and the max is $6.92 (ROI 0; sentiment NEUTRAL). By 2027 the avg rises to $6.36 with a max of $8.62 and ROI of 39.1 (sentiment BULLISH).
The path continues higher in 2028 ($7.18 avg; $10.15 max; ROI 57.1), 2029 ($8.83 avg; $12.17 max; ROI 82.3), and 2030 ($8.24 avg; $12.38 max; ROI 80.4). The forecast extends through 2050, with notable milestones such as 2035 avg $14.20, 2040 avg $18.73 (ROI 309.7), and 2050 avg $38.47 (ROI 741.8); the 2050 max reaches $75.31. Overall, sentiment shifts to BULLISH across the long horizon, reflecting strong upside potential and rising averages, albeit with inherent uncertainty and risk.
Tap a question to reveal the answer.
The 2030 forecast shows an avg price of $8.24, with a min of $5.94 and a max of $12.38, and a projected ROI of 80.4% with a BULLISH sentiment.
Near term (2026) is neutral with a min of $3.66, avg $4.57, max $6.92 and ROI 0, followed by a shift to bullish sentiment in subsequent years as averages rise toward 2027–2035.
Yes. The forecast for 2050 shows a max of $75.31 with an avg of $38.47 and a very high ROI of 741.8% under bullish sentiment.
Current price is $4.57 and market cap is $171.42M. The company is ranked 3921 in market capitalization.
The 30-day picture is bearish with RSI14 at 30. Key levels are support at $4.57 and resistance at $5.80, while the 30-day range spans from $3.71 to $5.63. SMA50 is $5.11 and SMA200 is $6.45.
Lifecore Biomedical, Inc. Community Discussion
0Share your Lifecore Biomedical, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.